Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

被引:0
|
作者
Konidaris, V.
Gorgoli, K.
Burgula, S.
Deane, J.
Banerjee, S.
Empeslidis, T.
机构
关键词
D O I
10.1111/j.1755-3768.2016.0316
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Vasileios E. Konidaris
    Konstantinos T. Tsaousis
    Rossella Anzidei
    Guillermo de la Mata
    Alexander J. Brent
    Ophthalmology and Therapy, 2018, 7 : 387 - 395
  • [22] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Konidaris, Vasileios E.
    Tsaousis, Konstantinos T.
    Anzidei, Rossella
    de la Mata, Guillermo
    Brent, Alexander J.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 387 - 395
  • [23] Early treatment with ranibizumab in severe central retinal vein occlusion
    Rostaqui, Olga
    Glacet-Bernard, Agnes
    Massamba, Nathalie
    Zerbib, Jennyfer
    Coscas, Florence
    Coscas, Gabriel
    Souied, Eric
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Ranibizumab treatment of retinal vein occlusion
    Johnson, Robert N.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2012, 7 (06) : 509 - 515
  • [25] Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema
    Kotake, Osamu
    Noma, Hidetaka
    Yasuda, Kanako
    Motohashi, Ryosuke
    Goto, Hiroshi
    Shimura, Masahiko
    OPHTHALMIC RESEARCH, 2019, 61 (04) : 210 - 217
  • [26] Aflibercept versus bevacizumab and/or ranibizumab for recurrent macular edema secondary to central retinal vein occlusion
    Dedania, Vaidehi
    Ozgonul, Cem
    Besirli, Cagri G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [27] Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
    Ozgonul, Cem
    Dedania, Vaidehi S.
    Besirli, Cagri G.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (04) : 340 - 345
  • [28] Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion
    Traustason, Sindri
    la Cour, Morten
    Larsen, Michael
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1208 - 1211
  • [29] Intravitreal aflibercept use in the treatment of macular edema from central retinal vein occlusion
    Carle, Michelle V.
    Chu, Thomas G.
    Tabandeh, Homayoun
    Boyer, David S.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (03) : 227 - 235
  • [30] EFFECTS OF SWITCHING TO AFLIBERCEPT IN THE TREATMENT OF MACULAR OEDEMA SECONDARY TO RETINAL VEIN OCCLUSION
    Spooner, Kimberly
    Hong, Thomas
    Fraser-Bell, Samantha
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 124 - 124